Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
The demand follows a High Court decision rejecting an attempt by the 21 former advisers to suspend the January ruling.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果